Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

Patients with chronic kidney disease (CKD) develop increased levels of the phosphate-regulating hormone, fibroblast growth factor (FGF) 23, that are associated with a higher risk of mortality. Increases in inflammatory markers are another common feature of CKD that predict poor clinical outcomes. El...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int
Main Authors: Singh, Saurav, Grabner, Alexander, Yanucil, Christopher, Schramm, Karla, Czaya, Brian, Krick, Stefanie, Czaja, Mark J., Bartz, Rene, Abraham, Reimar, Di Marco, Giovana Seno, Brand, Marcus, Wolf, Myles, Faul, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065745/
https://ncbi.nlm.nih.gov/pubmed/27457912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2016.05.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados